OXiGENE, Inc. (NASDAQ:OXGN) Is the Biggest Gainers - OXGN, SUTR, DeVry, BIOL, AAP

Lakeway, TX -- (SBWIRE) -- 02/07/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

OXiGENE, Inc. (NASDAQ:OXGN) shares climbed 19.94% to $5.24 in the early hour after the company yesterday announced that the randomized Phase 2 study evaluating the combination of ZYBRESTAT® (fosbretabulin tromethamine or CA4P) and Avastin® (bevacizumab) to treat patients with persistent or recurrent ovarian cancer has again demonstrated acceptable tolerability in the second and final scheduled interim toxicity analysis.

Is OXGN after A Solid Pop Up? Find Out Here

Sutor Technology Group Ltd. (NASDAQ:SUTR) shares soared 24.75% to $1.26 in the morning hour after the company today announced its financial results for fiscal 2013 second quarter ended December 31, 2012. Revenue generated from domestic sales increased by 49.2% to $139.6 million, while revenue generated from international sales increased by 27.5% to $18.3 million. As a percentage of total revenue, international sales accounted for 11.6%, as compared to 13.3% in the same quarter of fiscal 2012.

How Should Investors Trade SUTR After The recent Report? Find Out Here

DeVry Inc. (NYSE:DV) shares gained 20.44% to $31.46 after the company yesterday said that its second quarter net income was $50.29 million or $0.78 per share, up from $8.87 million or $0.13 per share for the year-ago quarter. Adjusted earnings for thelatest quarter were $56.23 million or $0.87 per share. Analysts expected the company to earn $0.56 per share for the quarter. Total revenue for the second quarter declined 4% to $505.24 million from $524.05 million in the year-ago period, but beat analysts' consensus estimate of $496.58 million.

Why Should Investors Consider Buying DV Now? Find Out Here

BIOLASE Inc (NASDAQ:BIOL) shares jumped 5.33% to $3.56 after the company yesterday announced that the U.S. Food and Drug Administration (FDA) has cleared the 940nm Diolase 10 diode soft tissue laser for use in 19 additional medical markets including: ear, nose and throat, oral surgery, arthroscopy, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery, thoracic surgery, urology, dermatology, aesthetics, and vascular surgery. This FDA clearance includes over 80 different procedures.

How Should Investors Trade BIOL After The recent Report? Find Out Here

Advance Auto Parts, Inc. (NYSE:AAP) stock jumped 7.86% to $78.70 after the company today reported a fourth quarter profit of $65 million, or 88 cents a share, versus $66.4 million, or 90 cents a share, a year earlier. Revenue edged up 0.1% to $1.33 billion. Analysts had most recently forecast per-share earnings of 75 cents on revenue of $1.33 billion.

Is AAP Still a Buy After The Recent momentum? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.